Publications dans lesquelles il/elle collabore avec MARTA ALVAREZ ESTEVEZ (16)

2022

  1. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

2020

  1. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  2. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2017

  1. High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach

    PLoS ONE, Vol. 12, Núm. 10

  2. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  2. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

  3. Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain

    PLoS ONE, Vol. 11, Núm. 12

2014

  1. Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes

    AIDS, Vol. 28, Núm. 12, pp. 1835-1837

2013

  1. Quantification of viral loads lower than 50 copies per milliliter by use of the cobas ampliprep/cobas taqman HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter

    Journal of Clinical Microbiology, Vol. 51, Núm. 5, pp. 1555-1557

2011

  1. Predicting antiretroviral drug resistance from the latest or the cumulative genotype

    Antiviral Therapy, Vol. 16, Núm. 3, pp. 373-381

2009

  1. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

    Journal of Medical Virology, Vol. 81, Núm. 5, pp. 763-767

  2. Resistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 2, pp. 75-80